HEALTH & WELL BEING DRUG DISCOVERY

[Interview] Expediting Drug Discovery Through Advanced Machine Learning

post-cover-268.png

The application of next-generation data analytics tools, powered by machine learning and artificial intelligence (AI) components, has become a long-term strategic priority for most companies in the pharmaceutical and biotech industries. However, such systems have to make sure the organisational data is findable, accessible, interoperable, and reusable across different sub-systems, applications, departments, teams, and even companies. 

Aigenpulse, a technology company at the forefront of data management and analytics in the Life Science industry, has built a portfolio of tools for working with organisational research data at scale and accelerating the discovery and development of better targets and candidates using advanced machine learning technologies.






Read more on Latest posts from BiopharmaTrend.com

You may also like

Comments are closed.